Q QUINTILES
DEAD

Serial Number

77236902

Owner

QUINTILES TRANSNATIONAL CORP.

Attorney

Arlene D. Hanks

First Use Date

Jul 28, 1998

Filing Date

Jul 24, 2007

Add to watchlist:

No watchlists yet
View on USPTO

Q QUINTILES Trademark

Serial Number: 77236902 • Registration: 3565435

Q QUINTILES is a trademark filed by QUINTILES TRANSNATIONAL CORP. on July 24, 2007. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

QUINTILES TRANSNATIONAL CORP. (78 trademarks)

Suite 200
Durham, NC 27703

Entity Type: 03

Trademark Details

Filing Date

July 24, 2007

Registration Date

January 20, 2009

First Use Anywhere

July 28, 1998

First Use in Commerce

July 28, 1998

Published for Opposition

March 18, 2008

Cancellation Date

August 23, 2019

Goods & Services

Educational and training services, namely, conducting training programs, seminars, classes, conferences and workshops in the fields of health care, health management and disease management, pharmaceutical sales skills, and pharmaceutical and health products, and distributing course materials in connection therewith

Computerized database management and data processing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; manufacturers' and independent sales representatives in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; marketing services for others, namely, creating and managing product sales and product launch programs in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; business marketing consulting services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; market research and analysis services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; personnel recruitment and placement; providing business information, namely, information useful for achieving and maintaining regulatory approval and market introduction of drugs, devices and biologics

Regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation services in the field of compliance evaluation to insure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consulting services in the fields of regulatory affairs, manufacturing compliance and validation; providing regulatory information and implementation services relating to the development and validation of drugs, devices and biologics

Providing health, medical, pharmaceutical, health management and disease management information to others; medical evaluation services, namely, developing and implementing disease management and treatment protocols and patient outcome analysis services; consulting services in the fields of health care, medical and pharmaceuticals

Clinical research and testing services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; product development consultation in the fields of medical products and devices; healthcare policy research and development services; laboratory testing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managing, monitoring and coordinating clinical studies on human subjects for others

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Aug 23, 2019 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 20, 2018 REM2
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 19, 2016 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 12, 2016 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 27, 2015 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 20, 2015 ASCK
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 27, 2015 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 27, 2015 C15A
AMENDMENT UNDER SECTION 7 - PROCESSED
Jan 27, 2015 A7OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 21, 2015 APRE
TEAS SECTION 7 REQUEST RECEIVED
Jan 16, 2015 ES7R
TEAS SECTION 8 & 15 RECEIVED
Jan 16, 2015 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 17, 2014 TCCA
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 22, 2009 ASCK
REGISTERED-PRINCIPAL REGISTER
Jan 20, 2009 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Dec 18, 2008 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 17, 2008 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 26, 2008 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 26, 2008 AITU
USE AMENDMENT FILED
Nov 20, 2008 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 20, 2008 EISU
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 10, 2008 NOAM
PUBLISHED FOR OPPOSITION
Mar 18, 2008 PUBO
NOTICE OF PUBLICATION
Feb 27, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 13, 2008 PREV
ASSIGNED TO LIE
Feb 13, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 14, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 26, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 26, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 26, 2007 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 23, 2007 GNRN
NON-FINAL ACTION E-MAILED
Oct 23, 2007 GNRT
NON-FINAL ACTION WRITTEN
Oct 23, 2007 CNRT
EXAMINER'S AMENDMENT ENTERED
Oct 19, 2007 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 19, 2007 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 19, 2007 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 19, 2007 CNEA
ASSIGNED TO EXAMINER
Oct 17, 2007 DOCK
NEW APPLICATION ENTERED
Jul 27, 2007 NWAP